|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
OLC1828206709 |
003 |
DE-627 |
005 |
20230516131031.0 |
007 |
tu |
008 |
091023s2009 xx ||||| 00| ||und c |
028 |
5 |
2 |
|a sw091020
|
035 |
|
|
|a (DE-627)OLC1828206709
|
035 |
|
|
|a (DE-599)GBVOLC1828206709
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
082 |
0 |
4 |
|a 570
|a 610
|
084 |
|
|
|a PHARM
|2 fid
|
084 |
|
|
|a XA 24552
|q AVZ
|2 rvk
|
084 |
|
|
|a 44.38
|2 bkl
|
084 |
|
|
|a 44.43
|2 bkl
|
084 |
|
|
|a 44.40
|2 bkl
|
100 |
1 |
|
|a Daurel, Claire
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Emergence of an Enterobacter hormaechei Strain with Reduced Susceptibility to Tigecycline under Tigecycline Therapy
|
264 |
|
1 |
|c 2009
|
300 |
|
|
|a 2
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
700 |
1 |
|
|a Fiant, Anne-Lise
|4 oth
|
700 |
1 |
|
|a Brémont, Sylvie
|4 oth
|
700 |
1 |
|
|a Courvalin, Patrice
|4 oth
|
700 |
1 |
|
|a Leclercq, Roland
|4 oth
|
773 |
0 |
8 |
|i Enthalten in
|t Antimicrobial agents and chemotherapy
|d Washington, DC : American Society for Microbiology, 1962
|g 53(2009), 11, Seite 4953-4954
|w (DE-627)129542318
|w (DE-600)217602-6
|w (DE-576)01499142X
|x 0066-4804
|7 nnns
|
773 |
1 |
8 |
|g volume:53
|g year:2009
|g number:11
|g pages:4953-4954
|g extent:2
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_OLC
|
912 |
|
|
|a FID-PHARM
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a SSG-OLC-DE-84
|
912 |
|
|
|a SSG-OPC-PHA
|
912 |
|
|
|a GBV_ILN_20
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_62
|
912 |
|
|
|a GBV_ILN_2006
|
912 |
|
|
|a GBV_ILN_4012
|
912 |
|
|
|a GBV_ILN_4112
|
912 |
|
|
|a GBV_ILN_4219
|
912 |
|
|
|a GBV_ILN_4305
|
936 |
r |
v |
|a XA 24552
|
936 |
b |
k |
|a 44.38
|q AVZ
|
936 |
b |
k |
|a 44.43
|q AVZ
|
936 |
b |
k |
|a 44.40
|q AVZ
|
951 |
|
|
|a AR
|
952 |
|
|
|d 53
|j 2009
|e 11
|h 4953-4954
|g 2
|